39008492|t|6-shogaol against 3-Nitropropionic acid-induced Huntington's disease in rodents: Based on molecular docking/targeting pro-inflammatory cytokines/NF-kappaB-BDNF-Nrf2 pathway.
39008492|a|BACKGROUND: Huntington's disease (HD) is an extremely harmful autosomal inherited neurodegenerative disease. Motor dysfunction, mental disorder, and cognitive deficits are the characteristic features of this disease. The current study examined whether 6-shogaol has a protective effect against 3-Nitropropionic Acid (3-NPA)-induced HD in rats. METHODS: A total of thirty male Wistar rats received 6-shogaol (10 and 20 mg/kg, per oral) an hour before injection of 3-NPA (10 mg/kg i.p.) for 15 days. Behavioral tests were performed, including narrow beam walk, rotarod test, and grip strength test. Biochemical tests promoting oxidative stress were evaluated [superoxide dismutase (SOD), reduced glutathione (GSH), catalase (CAT) and malondialdehyde (MDA)], including changes to neurotransmitters serotonin (5-HT), dopamine (DA), norepinephrine (NE), homovanillic acid (HVA), (3,4-dihydroxyphenylacetic acid (DOPAC), gamma-aminobutyric acid (GABA), and 5-hydroxy indole acetic acid (5-HIAA), nuclear factor kappa-B (NF-kappaB), tumor necrosis factor-alpha (TNF-alpha), interleukins-1beta (IL-1beta), IL-6, brain-derived neurotrophic factor (BDNF), and nuclear factor erythroid 2-related factor 2 (Nrf2). The 6-shogaol was docked to the active site of TNF-alpha (2AZ5), NF-kappaB (1SVC), BDNF) [1B8M], and Nrf2 [5FZN] proteins using AutoDock tools. RESULTS: The 6-shogaol group significantly improved behavioral activity over the 3-NPA-injected control rats. Moreover, 3-NPA-induced significantly altered neurotransmitters, biochemical and neuroinflammatory indices, which could efficiently be reversed by 6-shogaol. The 6-shogaol showed favorable negative binding energies at -9.271 (BDNF) kcal/mol. CONCLUSIONS: The present investigation demonstrated the neuroprotective effects of 6-shogaol in an experimental animal paradigm against 3-NPA-induced HD in rats. The suggested mechanism is supported by immunohistochemical analysis and western blots, although more research is necessary for definite confirmation.
39008492	0	9	6-shogaol	Chemical	MESH:C040115
39008492	18	39	3-Nitropropionic acid	Chemical	MESH:C015392
39008492	48	68	Huntington's disease	Disease	MESH:D006816
39008492	122	134	inflammatory	Disease	MESH:D007249
39008492	155	159	BDNF	Gene	24225
39008492	160	164	Nrf2	Gene	83619
39008492	186	206	Huntington's disease	Disease	MESH:D006816
39008492	208	210	HD	Disease	MESH:D006816
39008492	236	281	autosomal inherited neurodegenerative disease	Disease	MESH:D020271
39008492	283	300	Motor dysfunction	Disease	MESH:D000068079
39008492	302	317	mental disorder	Disease	MESH:D001523
39008492	323	341	cognitive deficits	Disease	MESH:D003072
39008492	426	435	6-shogaol	Chemical	MESH:C040115
39008492	468	489	3-Nitropropionic Acid	Chemical	MESH:C015392
39008492	491	496	3-NPA	Chemical	MESH:C015392
39008492	506	508	HD	Disease	MESH:D006816
39008492	512	516	rats	Species	10116
39008492	557	561	rats	Species	10116
39008492	571	580	6-shogaol	Chemical	MESH:C040115
39008492	637	642	3-NPA	Chemical	MESH:C015392
39008492	868	879	glutathione	Chemical	MESH:D005978
39008492	881	884	GSH	Chemical	MESH:D005978
39008492	887	895	catalase	Gene	24248
39008492	897	900	CAT	Gene	24248
39008492	906	921	malondialdehyde	Chemical	MESH:D008315
39008492	923	926	MDA	Chemical	MESH:D008315
39008492	969	978	serotonin	Chemical	MESH:D012701
39008492	980	984	5-HT	Chemical	MESH:D012701
39008492	987	995	dopamine	Chemical	MESH:D004298
39008492	997	999	DA	Chemical	MESH:D004298
39008492	1002	1016	norepinephrine	Chemical	MESH:D009638
39008492	1018	1020	NE	Chemical	MESH:D009638
39008492	1023	1040	homovanillic acid	Chemical	MESH:D006719
39008492	1042	1045	HVA	Chemical	MESH:D006719
39008492	1049	1079	3,4-dihydroxyphenylacetic acid	Chemical	MESH:D015102
39008492	1081	1086	DOPAC	Chemical	MESH:D015102
39008492	1089	1112	gamma-aminobutyric acid	Chemical	MESH:D005680
39008492	1114	1118	GABA	Chemical	MESH:D005680
39008492	1125	1153	5-hydroxy indole acetic acid	Chemical	MESH:D006897
39008492	1155	1161	5-HIAA	Chemical	MESH:D006897
39008492	1200	1227	tumor necrosis factor-alpha	Gene	24835
39008492	1229	1238	TNF-alpha	Gene	24835
39008492	1261	1269	IL-1beta	Gene	24494
39008492	1272	1276	IL-6	Gene	24498
39008492	1278	1311	brain-derived neurotrophic factor	Gene	24225
39008492	1313	1317	BDNF	Gene	24225
39008492	1324	1367	nuclear factor erythroid 2-related factor 2	Gene	83619
39008492	1369	1373	Nrf2	Gene	83619
39008492	1380	1389	6-shogaol	Chemical	MESH:C040115
39008492	1423	1432	TNF-alpha	Gene	24835
39008492	1459	1463	BDNF	Gene	24225
39008492	1477	1481	Nrf2	Gene	83619
39008492	1533	1542	6-shogaol	Chemical	MESH:C040115
39008492	1601	1606	3-NPA	Chemical	MESH:C015392
39008492	1624	1628	rats	Species	10116
39008492	1640	1645	3-NPA	Chemical	MESH:C015392
39008492	1711	1728	neuroinflammatory	Disease	MESH:D000090862
39008492	1777	1786	6-shogaol	Chemical	MESH:C040115
39008492	1792	1801	6-shogaol	Chemical	MESH:C040115
39008492	1856	1860	BDNF	Gene	24225
39008492	1955	1964	6-shogaol	Chemical	MESH:C040115
39008492	2008	2013	3-NPA	Chemical	MESH:C015392
39008492	2022	2024	HD	Disease	MESH:D006816
39008492	2028	2032	rats	Species	10116
39008492	Positive_Correlation	MESH:C015392	MESH:D006816
39008492	Association	MESH:C040115	24225
39008492	Association	MESH:C040115	83619
39008492	Association	MESH:C040115	MESH:D007249
39008492	Association	MESH:D006816	83619
39008492	Positive_Correlation	MESH:C015392	MESH:D000090862
39008492	Negative_Correlation	MESH:C040115	MESH:D006816
39008492	Negative_Correlation	MESH:C015392	MESH:C040115
39008492	Association	MESH:C040115	24835
39008492	Association	MESH:C015392	83619

